Granulocyte Colony Stimulating Factor (G-CSF) can allow treatment with clozapine in a patient with severe Benign Ethnic Neutropaenia (BEN): a case report

Clozapine is the treatment of choice for treatment-resistant schizophrenia, but it is associated with a risk of neutropaenia and agranulocytosis. Clozapine use is regulated by mandatory blood monitoring in the UK, requiring cessation of treatment should the absolute neutrophil count (ANC) drop below...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychopharmacology (Oxford) Vol. 26; no. 9; pp. 1280 - 1282
Main Authors: Spencer, Benjamin WJ, Williams, Hugh RJ, Gee, Siobhan H, Whiskey, Eromona, Rodrigues, Joseph P, Mijovic, Aleksandar, MacCabe, James H
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01-09-2012
Sage Publications
Sage Publications Ltd
Subjects:
BEN
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first